Boc-Trilaciclib DBU salt

SL-11777

Boc-Trilaciclib DBU salt, >98%

IUPAC Name : tert-Butyl 2'-chloro-5'-hydroxy-6'-oxo-6'H-spiro[cyclohexane-1,9'-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylate--2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine (1/1)

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
100MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is an advanced key intermediate in the synthesis of Trilaciclib and related analogs. Trilaciclib is an oral CDK4/6 inhibitor. It effectively suppresses tumour cell proliferation and helps reduce the blood-related toxicity associated with chemotherapy. Additionally, Trilaciclib lessens both apoptosis and myelosuppression caused by 5-Fluorouracil (5-FU) chemotherapy.

References : Bisi J. E. et al.: Mol Cancer Ther., 15(5), 783-93, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.